IVIM Health vs Lavender Sky Health vs MEDVi (2026)

On tirzepatide, the order is IVIM Health↗ ($278) → Lavender Sky Health↗ ($352) → MEDVi↗ ($399) — gaps of $74 and then $47 a month, a $1,452 spread across a year between first and last. All-in figures, 10 mg basis, captured 2026-08-09.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

§ Each record, condensed

The three records, one screen

IVIM Health: the record, condensed

Start with the load-bearing figure: $278 a month, all-in, is what IVIM Health charges for tirzepatide at the 10 mg basis. The structure is tiered: the advertised entry point is $208, but the maintenance figure — the one a full year is actually billed at — is $278. That $70 gap between the ad and the anniversary is the single most important line in this record.

Inside that $278 sits a mandatory $75-a-month membership. We fold it in automatically — the medication-only figure the marketing may lead with is $203, and it is not a price anyone can actually pay, because the membership cannot be declined.

Context for that figure: it ranks #3 of 17 in the verified tirzepatide index — $63/month above the floor (NexLife↗, $215) — and sits $171 under the brand benchmark (Zepbound (LillyDirect↗), $449 at maintenance). Annualized, a monthly-billed year here runs $3,336.

Start with the load-bearing figure: $149 a month, all-in, is what IVIM Health charges for semaglutide at the 2.4 mg basis. The figure is quoted at maintenance without a separate teaser tier, which keeps the arithmetic honest by default.

Inside that $149 sits a mandatory $75-a-month membership. We fold it in automatically — the medication-only figure the marketing may lead with is $74, and it is not a price anyone can actually pay, because the membership cannot be declined.

To place the number: #3 of 20 verified programs, with the floor $16/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare↗)) sits at $349, so the compounded case here is worth $200 a month. A year at this figure: $1,788 monthly-billed.

Operationally at IVIM Health: shipping included; commitment membership mandatory for duration; cancellation membership mandatory; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the IVIM Health page · visit IVIM Health ↗

Lavender Sky Health: the record, condensed

Start with the load-bearing figure: $352 a month, all-in, is what Lavender Sky Health charges for tirzepatide at the 10 mg basis. Note the shape: $200 is the number in the marketing, $352 is the number at maintenance. The $152 difference is not a fee or a trick per se — it is dose-tiered pricing doing what dose-tiered pricing does — but it means the advertised figure describes month one, not month twelve.

The all-in figure already contains a compulsory $25 monthly membership. That is the honest way to quote it: a bundled price is only misleading when its parts are advertised separately, and here the medication-only $327 would be exactly that kind of mirage.

Context for that figure: it ranks #12 of 17 in the verified tirzepatide index — $137/month above the floor (NexLife, $215) — and sits $97 under the brand benchmark (Zepbound (LillyDirect), $449 at maintenance). Annualized, a monthly-billed year here runs $4,224.

Lavender Sky Health’s semaglutide program bills $174 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. The figure is quoted at maintenance without a separate teaser tier, which keeps the arithmetic honest by default.

A required $25/month membership is part of the deal, and part of the figure above: $149 of medication plus $25 of platform equals the $174 that leaves your account. Judge the membership by what it includes, but compare on the total.

To place the number: #6 of 20 verified programs, with the floor $41/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare)) sits at $349, so the compounded case here is worth $175 a month. A year at this figure: $2,088 monthly-billed.

Operationally at Lavender Sky Health: shipping included; commitment monthly plan fee recurs; cancellation plan fee recurs until cancelled; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the Lavender Sky Health page · visit Lavender Sky Health ↗

MEDVi: the record, condensed

Start with the load-bearing figure: $399 a month, all-in, is what MEDVi charges for tirzepatide at the 10 mg basis. Because pricing is flat across the ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)), a dose increase at MEDVi is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.

Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $399 is the whole subscription, which makes MEDVi unusually easy to compare and unusually easy to leave.

To place the number: #14 of 17 verified programs, with the floor $184/month below at NexLife ($215); the approved-product yardstick (Zepbound (LillyDirect)) sits at $449, so the compounded case here is worth $50 a month. A year at this figure: $4,788 monthly-billed.

MEDVi’s semaglutide program bills $299 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. Because pricing is flat across the ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg), a dose increase at MEDVi is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.

Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $299 is the whole subscription, which makes MEDVi unusually easy to compare and unusually easy to leave.

Context for that figure: it ranks #18 of 20 in the verified semaglutide index — $166/month above the floor (Oak Longevity, $133) — and sits $50 under the brand benchmark (Wegovy (NovoCare), $349 at maintenance). Annualized, a monthly-billed year here runs $3,588.

Operationally at MEDVi: shipping included; commitment 12-month plan for the lowest rate; cancellation 12-month plan applies to lowest rate; pharmacy not publicly named — ask in writing before paying; states: priced differently in CA/NC on some plans; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the MEDVi page · visit MEDVi ↗

§ The three-way read

Prices, gaps, and what sits inside them

IVIM Health holds the low ground at $278 (its $75 membership already inside). Lavender Sky Health follows at $352 (+$74/mo, $888/yr), membership included. MEDVi tops the trio at $399 (+$121/mo over the leader, $1,452/yr) — note its record’s watch-out below.

The semaglutide picture reshuffles nothing: IVIM Health $149 → Lavender Sky Health $174 → MEDVi $299 — a reminder that molecule choice and provider choice are separate decisions, priced separately in the semaglutide index.

§ Category winners among the three

Who wins what

Cheapest month-to-month: IVIM Health ($278); cheapest 12-month path: IVIM Health ($3,336); simplest billing (no membership): MEDVi; dose-flat structure: MEDVi; cheapest semaglutide of the three: IVIM Health ($149).

Every winner above is a computation, not a placement; the pairwise pages carry the full duels: IVIM Health vs Lavender Sky Health (record · record) · IVIM Health vs MEDVi · Lavender Sky Health vs MEDVi (record · record).

§ Structure, three ways

Everything besides the three prices

Memberships: IVIM Health $75/mo (inside its figure); Lavender Sky Health $25/mo (inside its figure); MEDVi none. Structures: IVIM Health step/tiered; Lavender Sky Health step/tiered; MEDVi dose-flat. Pharmacies: IVIM Health not named; Lavender Sky Health not named; MEDVi not named. States: IVIM Health — not published; Lavender Sky Health — not published; MEDVi — priced differently in CA/NC on some plans. Exit terms: IVIM Health — membership mandatory; Lavender Sky Health — plan fee recurs until cancelled; MEDVi — 12-month plan applies to lowest rate.

The census reading: where all three match on an axis, that axis cannot break the tie and the price column rules; where they split — a membership here, an unnamed pharmacy there — the split is usually worth more than a small price gap, because structure is what you live with after month one. Evidence for all three: IVIM Health source-verified (2026-08-05); Lavender Sky Health source-verified (2026-08-05); MEDVi source-verified (2026-08-05).

The trio on semaglutide, across time

3 mo: IVIM Health $447 vs Lavender Sky Health $522 vs MEDVi $897 6 mo: IVIM Health $894 vs Lavender Sky Health $1,044 vs MEDVi $1,794 12 mo: IVIM Health $1,788 vs Lavender Sky Health $2,088 vs MEDVi $3,588 — monthly-billed totals; prepaid paths where published appear on each provider page.

§ Twelve and twenty-four months

The trio, annualized

IVIM Health: $3,336/yr monthly-billed; Lavender Sky Health: $4,224/yr monthly-billed; MEDVi: $4,788/yr monthly-billed. Across two years at monthly billing the first-to-last spread widens to $2,904 — the horizon at which structure (prepaid ladders, flat pricing, membership drag) matters more than the sticker.

The elimination read

Work it as eliminations rather than a beauty contest. MEDVi enters owing an explanation: $121/month above IVIM Health compounds to $1,452 a year — real therapy-months of money — so its record has to name what the premium buys (structure the cheaper two lack) or it exits first. Lavender Sky Health survives the first cut only to face the harder question — whether nothing structural — its case is purely situational is worth $74 a month to you — because a middle option that cannot answer it is just the expensive option with better camouflage. IVIM Health is what remains: the arithmetic answer at $278, dethroned only by a state gap, a structural need, or a prescriber’s judgment — the three things this page deliberately cannot decide.

The same trio on best published rate: IVIM Health $278 → Lavender Sky Health $352 → MEDVi $399 — all three price month-to-month only at capture. Short-horizon totals, monthly-billed: 3 months — IVIM Health $834, Lavender Sky Health $1,056, MEDVi $1,197; 6 months — IVIM Health $1,668, Lavender Sky Health $2,112, MEDVi $2,394. 0 of the three publish a prepaid path below their own monthly billing; the twelve- and twenty-four-month table below carries those, labeled.

Grade the three records before trusting the three prices. On the five-point disclosure checklist (price, pharmacy, states, cancellation, source-verification): IVIM Health 4/5 · Lavender Sky Health 4/5 · MEDVi 4/5. Even scores across the board — so this particular trio really is a pure price-and-structure decision. No axis splits them, a small collective credit. Every score is a computation from the dataset, contestable at the corrections desk like any other figure.

The three-way verdict compresses cleanly: IVIM Health is the default on arithmetic; Lavender Sky Health earns the middle only where its structure (membership services) solves something the floor does not; and MEDVi’s $121/month premium over the leader — $1,452 a year, roughly 5.2 extra months of therapy at the floor rate — needs a named justification from its record, not a vibe. Insurance coverage, where it exists, outranks all three.